The voltage gated calcium channel family is a major target for a range of t
herapeutic drugs. Mibefradil (Ro 40-5967) belongs to a new chemical class o
f these molecules which differs from other Ca2+ antagonists by its ability
to potently block T-type Ca2+ channels. However, this molecule has also bee
n shown to inhibit other Ca2+ channel subtypes. To further analyze the mech
anism governing the Ca2+ channel-Mibefradil interaction, we examined the ef
fect of Mibefradil on various recombinant Ca2+ channels nov expressed in ma
mmalian cells from their cloned cDNAs, using Ca2+ as the permeant ion at ph
ysiological concentration. Expression of a(1A) a(1C) and a(1E) in tsA 201 c
ells resulted in Ca2+ currents with functional characteristics closely rela
ted to those of their native counterparts. Mibefradil blocked alpha(1A) and
ct,, with a Kd comparable to that reported for T-type channels, but had a
lower affinity (similar to 30-fold) for alpha(1C). For each channel, inhibi
tion by Mibefradil was consistent with high-affinity binding to the inactiv
ated state. Modulation of the voltage-dependent inactivation properties by
the nature of the coexpressed beta subunit or the al splice variant altered
block at the Mibefradil receptor site. Therefore, we conclude that the tis
sue and sub-cellular localization of calcium channel subunits as well as th
eir specific associations are essential parameters to understand the in viv
o effects of Mibefradil. (C) 1999 Elsevier Science Ltd. All rights reserved
.